×
About 63,783 results

ALLMedicine™ Thrombosis Center

Research & Reviews  22,132 results

Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocyto...
https://doi.org/10.1177/19714009211036687
The Neuroradiology Journal; Yahyavi-Firouz-Abadi N, Naik RP

Aug 3rd, 2021 - Thrombosis-thrombocytopenia syndrome and cerebral venous sinus thrombosis have been rarely reported in patients who have received severe acute respiratory syndrome coronavirus 2 adenoviral vector vaccines. Awareness of this potential adverse effec...

Prospective Trial of Near-Infrared Spectroscopy for Continuous Noninvasive Monitoring o...
https://doi.org/10.1097/SAP.0000000000002915
Annals of Plastic Surgery; Ouyang SY, Cai ZG et. al.

Aug 3rd, 2021 - Some free flaps develop postoperative vessel thrombosis, which influences the flap survival rate. Early discovery and identification of vascular crisis are critical to the success rate of flap salvage. The primary aims of this study were to determ...

Left Lobe Living Donor Liver Transplantation using Rapid Procedure in a Cirrhotic Patie...
https://doi.org/10.1097/SLA.0000000000005107
Annals of Surgery; Balci D, Kirimker EO et. al.

Aug 3rd, 2021 - Left Lobe Living Donor Liver Transplantation using Rapid Procedure in a Cirrhotic Patient with Portal Vein Thrombosis.|2021|Balci D,Kirimker EO,Kologlu MB,Ustuner E,Erkoc SK,|

Retinal, Optic Nerve, and Cerebral Infarction in Odontogenic Lemierre Syndrome.
https://doi.org/10.1097/WNO.0000000000001332
Journal of Neuro-ophthalmology : the Official Journal of ... Halawa A, Kim J et. al.

Aug 3rd, 2021 - A 61-year-old healthy woman developed congestive orbitopathy, and bilateral retinal, optic nerve, and cerebral infarctions after removal of a chipped molar tooth. Ophthalmoscopy disclosed multiple retinal arteriolar occlusions and pallid swelling ...

Acquired Thrombotic Thrombocytopenic Purpura Without Anti-ADAMTS13 Antibody Caused by I...
https://doi.org/10.12659/AJCR.932251
The American Journal of Case Reports; Kubo K, Abe T et. al.

Aug 3rd, 2021 - BACKGROUND Thrombotic microangiopathy, characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage by microvascular thrombosis, has a high mortality rate; therefore, early diagnosis and treatment are important. Thromboti...

see more →

Guidelines  59 results

Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Cli...
https://doi.org/10.1016/j.jacc.2021.02.038
Journal of the American College of Cardiology; , Généreux P et. al.

Apr 24th, 2021 - The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evol...

American Society of Hematology 2020 guidelines for management of venous thromboembolism...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556153
Blood Advances; Ortel TL, Neumann I et. al.

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.
https://doi.org/10.1016/j.clinre.2020.03.016
Clinics and Research in Hepatology and Gastroenterology; Elkrief L, Houssel-Debry P et. al.

Aug 21st, 2020 - Chronic non cirrhotic extrahepatic portal vein obstruction (EHPVO) refers to the cavernomatous transformation of the portal vein (the so-called "portal cavernoma") which occurs following acute thrombosis of the portal vein in the absence of recana...

ACR Appropriateness Criteria® Radiologic Management of Iliofemoral Venous Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.035
Journal of the American College of Radiology : JACR; , Farsad K et. al.

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

ACR Appropriateness Criteria® Suspected Upper Extremity Deep Vein Thrombosis.
https://doi.org/10.1016/j.jacr.2020.01.020
Journal of the American College of Radiology : JACR; , Desjardins B et. al.

May 7th, 2020 - This publication includes the appropriate imaging modalities to assess suspected deep vein thrombosis in the upper extremities. Ultrasound duplex Doppler is the most appropriate imaging modality to assess upper-extremity deep vein thrombosis. It i...

see more →

Drugs  335 results see all →

Clinicaltrials.gov  766 results

XIENCE 28 Global Study
https://clinicaltrials.gov/ct2/show/NCT03355742

May 6th, 2020 - The XIENCE 28 Global Study will evaluate the safety of 1-month DAPT following XIENCE implantation in HBR patients. A minimum of 800 to a maximum of 960 subjects will be registered from approximately 50 sites globally and subject registration is ca...

Stroke and Cerebrovascular Diseases Registry
https://clinicaltrials.gov/ct2/show/NCT03281590

Apr 24th, 2020 - Stroke is the fifth cause of all-cause mortality in US http://www.cdc.gov/stroke/facts.htm Early identification and treatment not only prevent mortality but also morbidity. Recent advancement in the imaging and diagnostic technique and novel thera...

Apixaban Pharmacokinetics in Bariatric Patients (APB)
https://clinicaltrials.gov/ct2/show/NCT02406885

Apr 21st, 2020 - Obesity is now the leading health problem of the 21st century. Weight reduction by conservative methods including diet and exercise has had poor success rates. There has been a substantial increase in the use of bariatric surgery to provide sustai...

Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO)
https://clinicaltrials.gov/ct2/show/NCT03209843

Apr 21st, 2020 - The objective of PERFECTO is to assess the reendothelialization at 3 months after successfully CTO percutaneous intervention (PCI) with new generation drug eluting stent (DES) by OFDI analysis. Designed as a multicentric, observational and prospec...

Bivalirudin vs Heparin in ECMO Patients
https://clinicaltrials.gov/ct2/show/NCT03707418

Apr 14th, 2020 - This open label randomized study will compare the clinical outcomes of patients on ECMO who are anticoagulated with Heparin and Bivalirudin. Patients will be anticoagulated with a heparin bolus at the commencement of ECMO per standard of care, as ...

see more →

News  2,200 results

Genotype-Based Strategy Reduces Thrombotic Events After Watchman Implant
https://www.medscape.com/viewarticle/954762

Jul 15th, 2021 - NEW YORK (Reuters Health) - In patients receiving a Watchman heart device who are genetically predisposed to reduced clopidogrel metabolism, the use of aspirin plus a half-dose of a direct oral anticoagulant (DOAC) significantly reduces device-rel...

Chronic Anticoagulation Fails to Lower AKI Risk in COVID-19 Patients
https://www.medscape.com/viewarticle/954487

Jul 9th, 2021 - Takeaway Chronic anticoagulation does not reduce the risk of acute kidney injury (AKI) and its severity, including the need for renal replacement therapy (RRT) in hospitalised patients with COVID-19. Why this matters Findings suggest that renal mi...

A Woman With DVT After a Flight, Anemia, and Bowel Changes
https://www.medscape.com/viewarticle/855224

Jun 29th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Thrombosis With Thrombocytopenia After mRNA COVID-19 Vaccine
https://www.medscape.com/viewarticle/953901

Jun 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA COVID-19 vaccine has been reported. The case repor...

Abbott Vascular Recalls Coronary Catheters Due to Risks Stemming from Difficulty Removing Balloon Sheath | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/abbott-vascular-recalls-coronary-catheters-due-risks-stemming-difficulty-removing-balloon-sheath

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product(s): Abbott NC Trek RX Coronary Dilatation Catheter, Abbott NC Traveler Coronary Dilatation...

see more →

Patient Education  21 results see all →